Adam E Hansen1, Henrik Gutte2, Pernille Holst3, Helle H Johannesen2, Sofie Rahbek2, Andreas E Clemmensen2, Majbritt M E Larsen3, Christina Schøier3, Jan Ardenkjaer-Larsen4, Thomas L Klausen2, Annemarie T Kristensen3, Andreas Kjaer2. 1. Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Denmark. Electronic address: adam.espe.hansen@regionh.dk. 2. Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Denmark. 3. Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark. 4. Department of Electrical Engineering, Center for Hyperpolarization in Magnetic Resonance, Technical University of Denmark, Lyngby, Denmark.
Abstract
13C Magnetic Resonance Spectroscopy (MRS) using hyperpolarized 13C-labeled pyruvate as a substrate offers a measure of pyruvate-lactate interconversion and is thereby a marker of the elevated aerobic glycolysis (Warburg effect) generally exhibited by cancer cells. Here, we aim to compare hyperpolarized [1-13C]pyruvate MRS with simultaneous 18F-2-fluoro-2-deoxy-d-glucose (FDG) PET in a cross-sectional study of canine cancer patients. METHODS: Canine cancer patients underwent integrated PET/MRI using a clinical whole-body system. Hyperpolarized [1-13C]pyruvate was obtained using dissolution-DNP. 18F-FDG PET, dynamic 13C MRS, 13C MRS Imaging (MRSI) and anatomical 1H MRI was acquired from 17 patients. Apparent pyruvate-to-lactate rate constants were estimated from dynamic 13C MRS. 18F-FDG Standard Uptake Values and maximum [1-13C]lactate-to-total-13C ratios were obtained from tumor regions of interest. Following inspection of data, patients were grouped according to main cancer type and linear regression between measures of lactate generation and 18F-FDG uptake were tested within groups. Between groups, the same measures were tested for group differences. RESULTS: The main cancer types of the 17 patients were sarcoma (n = 11), carcinoma (n = 5) and mastocytoma (n = 1). Significant correlations between pyruvate-to-lactate rate constants and 18F-FDG uptake were found for sarcoma patients, whereas no significant correlations appeared for carcinoma patients. The sarcoma patients showed a non-significant trend towards lower 18F-FDG uptake and higher lactate generation than carcinoma patients. However, the ratio of lactate generation to 18F-FDG uptake was found to be significantly higher in sarcoma as compared to carcinoma. The results were found both when lactate generation was estimated as an apparent pyruvate-to-lactate rate constant from dynamic 13C MRS and as an [1-13C]lactate to total 13C ratio from 13C MRSI. CONCLUSIONS: A comparison of hyperpolarized [1-13C]pyruvate MRS with simultaneous 18F-FDG PET indicate that lactate generation and 18F-FDG uptake in cancers can be related and that their relation depend on cancer type. This finding could be important for the interpretation and eventual clinical implementation of hyperpolarized 13C. In addition, the differences between the two modalities may allow for better metabolic phenotyping performing hybrid imaging in the form of hyperPET.
13C Magnetic Resonance Spectroscopy (MRS) using hyperpolarized 13C-labeled pyruvate as a substrate offers a measure of pyruvate-lactate interconversion and is thereby a marker of the elevated aerobic glycolysis (Warburg effect) generally exhibited by cancer cells. Here, we aim to compare hyperpolarized [1-13C]pyruvateMRS with simultaneous 18F-2-fluoro-2-deoxy-d-glucose (FDG) PET in a cross-sectional study of caninecancerpatients. METHODS:Caninecancerpatients underwent integrated PET/MRI using a clinical whole-body system. Hyperpolarized [1-13C]pyruvate was obtained using dissolution-DNP. 18F-FDG PET, dynamic 13CMRS, 13CMRS Imaging (MRSI) and anatomical 1H MRI was acquired from 17 patients. Apparent pyruvate-to-lactate rate constants were estimated from dynamic 13CMRS. 18F-FDG Standard Uptake Values and maximum [1-13C]lactate-to-total-13C ratios were obtained from tumor regions of interest. Following inspection of data, patients were grouped according to main cancer type and linear regression between measures of lactate generation and 18F-FDG uptake were tested within groups. Between groups, the same measures were tested for group differences. RESULTS: The main cancer types of the 17 patients were sarcoma (n = 11), carcinoma (n = 5) and mastocytoma (n = 1). Significant correlations between pyruvate-to-lactate rate constants and 18F-FDG uptake were found for sarcomapatients, whereas no significant correlations appeared for carcinomapatients. The sarcomapatients showed a non-significant trend towards lower 18F-FDG uptake and higher lactate generation than carcinomapatients. However, the ratio of lactate generation to 18F-FDG uptake was found to be significantly higher in sarcoma as compared to carcinoma. The results were found both when lactate generation was estimated as an apparent pyruvate-to-lactate rate constant from dynamic 13CMRS and as an [1-13C]lactate to total 13C ratio from 13C MRSI. CONCLUSIONS: A comparison of hyperpolarized [1-13C]pyruvateMRS with simultaneous 18F-FDG PET indicate that lactate generation and 18F-FDG uptake in cancers can be related and that their relation depend on cancer type. This finding could be important for the interpretation and eventual clinical implementation of hyperpolarized 13C. In addition, the differences between the two modalities may allow for better metabolic phenotyping performing hybrid imaging in the form of hyperPET.
Authors: Kazutoshi Yamamoto; Jeffrey R Brender; Tomohiro Seki; Shun Kishimoto; Nobu Oshima; Rajani Choudhuri; Stephen S Adler; Elaine M Jagoda; Keita Saito; Nallathamby Devasahayam; Peter L Choyke; James B Mitchell; Murali C Krishna Journal: Cancer Res Date: 2020-04-03 Impact factor: 12.701
Authors: Benedikt Feuerecker; Michael Michalik; Christian Hundshammer; Markus Schwaiger; Frank Bruchertseifer; Alfred Morgenstern; Christof Seidl Journal: Sci Rep Date: 2019-06-05 Impact factor: 4.379
Authors: Geoffrey J Topping; Christian Hundshammer; Luca Nagel; Martin Grashei; Maximilian Aigner; Jason G Skinner; Rolf F Schulte; Franz Schilling Journal: MAGMA Date: 2019-12-06 Impact factor: 2.310
Authors: Andreas Clemmensen; Adam E Hansen; Pernille Holst; Christina Schøier; Sissel Bisgaard; Helle H Johannesen; Jan Henrik Ardenkjær-Larsen; Annemarie T Kristensen; Andreas Kjaer Journal: Eur J Nucl Med Mol Imaging Date: 2020-07-03 Impact factor: 9.236
Authors: Evelien A J van Genugten; Jetty A M Weijers; Sandra Heskamp; Manfred Kneilling; Michel M van den Heuvel; Berber Piet; Johan Bussink; Lizza E L Hendriks; Erik H J G Aarntzen Journal: Front Oncol Date: 2022-01-07 Impact factor: 6.244
Authors: Christian Hundshammer; Miriam Braeuer; Christoph A Müller; Adam E Hansen; Mathias Schillmaier; Stephan Düwel; Benedikt Feuerecker; Steffen J Glaser; Axel Haase; Wilko Weichert; Katja Steiger; Jorge Cabello; Franz Schilling; Jan-Bernd Hövener; Andreas Kjær; Stephan G Nekolla; Markus Schwaiger Journal: Theranostics Date: 2018-09-09 Impact factor: 11.556
Authors: Keshav Datta; Mette H Lauritzen; Milton Merchant; Taichang Jang; Shie-Chau Liu; Ralph Hurd; Lawrence Recht; Daniel M Spielman Journal: PLoS One Date: 2019-12-12 Impact factor: 3.240